People with Diabetes can get ready to celebrate: “The ‘Era of Lancets’ is over.” Precision nutrition startup, DayTwo, is scaling up its microbiome-based program, which takes the guesswork (and finger pricks) out of Diabetes management by offering its members food predictions that identify how their bodies will respond to any food BEFORE they eat it. The startup just closed a fresh $37M in Series B funding (led by aMoon and Cathay Ventures) and is expanding the rollout of their fee-for-outcomes Diabetes program to health plans and large self-insured employers.
The science behind this has yielded DayTwo the largest gut microbiome dataset in the world, and years of empirical studies on exactly what happens in our bodies as our digestive systems process different foods. Josh Stevens, DayTwo’s President & Chief Commercial Officer, walks us through the research behind the offering, which uses a gut microbiome analysis to rank foods and food combinations based on how eating them will impact a person’s blood sugar – essentially revealing what foods will (or won’t) cause a member’s blood sugar to spike before they even take a bite.
Its 70,000+ members report lower A1C levels (1 point on average), sustained weight loss, and, probably most exciting, an ability to stick with the program because the app (and wrap-around telehealth support from registered dieticians) creates a completely bespoke diet that lets people learn how to eat their favorite foods and keep their blood glucose levels within range. Will this predictive approach really bring about the end of lancet-based blood glucose testing for Diabetes management? Josh says Diabetes remission is a goal made easier by this predictive approach, but how does it stack up to other food-as-medicine approaches out there? I have a gut-feeling that you’ll want to tune in and find out!
Today at Health in 2 Point 00, Jess and I are presenting at the Going Digital: Behavioral Health conference today — tune in later for that. On Episode 212, our buddies at DayTwo get $37 million for the gut microbiome. Hello Heart raises $45 million, bringing their total to $68.2 million – this is for high blood pressure management. Pack4U, which is like the knockoff version of Pill Pack, raises $20 million. Swedish telemedicine company Doktor.se raises $50 million, and Curebase raises $15 million for decentralized clinical trials. —Matthew Holt
Launch! is always one of the most fun and most exciting sessions at Health 2.0. Ten new companies demo their product on stage for the very first time during at the 10th Annual Fall Conference. Previous Launch! winners have included Castlight Health, Basis, and OM*Signal and last year’s winner MedWand, which just beat out Gliimpse–itself since bought by Apple.
This year’s finalists are:
Valeet Healthcare‘s platform gives patients personalized health information while allowing providers to have a rounding tool and giving healthcare systems a dashboard to track metrics.
gripAble is an innovative mobile technology that bridges the gap between functional therapy and objective measurement of upper-limb function.
Cricket Health works with payor and provider customers to slow the progression of chronic kidney disease (CKD), manage the transition from CKD to End Stage Renal Disease, and improve ESRD care.
Qidza is a population health mobile platform that enables parents work with their physicians to track their children’s developmental milestones
Docent Health guides health systems to embrace a consumer-centric approach to healthcare by curating patient experiences.
Albeado builds Healthcare prediction and optimization solutions based on proprietary data science platform which combines clinical AI and Graph-Based Machine Learning.
Siren Care offers temperature-sensing smart socks which provide health data on foot ulcers, hot spots, and more to prevent future injuries.
MDwithME integrates soft and hardware components in a suitcase enabling full remote physical exams with an option of instant or delayed physician’s consult with quality of testing that equals or exceeds the current state of art.
DayTwomaintains health and prevent disease utilizing a microbiome platform, starting with personalized nutrition based on gut bacteria, aiming to normalize blood sugar levels and cultivate a healthy gut microbiome.
Regeneration Health is a health ecosystem powered by artificial intelligence that collects and monitors health in real time and curates free personalized health info and recommendations based on integrative medicine.